Vigene Biosciences Inc.
Vigene Biosciences Inc (Vigene) is an award-winning world leader in viral vector research and GMP manufacturing. Vigene’s mission is to make gene therapy affordable (TM). Headquartered in Rockville, MD (USA), Vigene offers both research grade and cGMP grade AAV, lentivirus, retrovirus, adenovirus and plasmids, serving over 2000 academic, biotech and pharmaceutical labs. Vigene is combining the proven and proprietary production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical material clients. Vigene has continued to serve both research and clinical communities and has been recognized with national awards. In mid-2019, Vigene’s new facility augments the total GMP, research and QC space to 71,000 square feet with 10 fully independent GMP suites to provide more opportunities for growth and innovation as the fields of gene and cell therapy continue to evolve.